Semaglutide once weekly in people with type 2 diabetes: Real‐world analysis of the Canadian LMC diabetes registry (SPARE study)

AIMS: To investigate real‐world short‐term clinical outcomes in adults with type 2 diabetes (T2D) who initiated semaglutide in a specialist endocrinology practice in Canada. MATERIALS AND METHODS: This study was a retrospective observational study using data from the Canadian LMC Diabetes Registry....

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Ruth E, Bech, Peter G, Aronson, Ronnie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689820/
https://www.ncbi.nlm.nih.gov/pubmed/32538541
http://dx.doi.org/10.1111/dom.14117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689820/
https://www.ncbi.nlm.nih.gov/pubmed/32538541
http://dx.doi.org/10.1111/dom.14117

Ejemplares similares